Santa Barbara Nutrients is a biotechnology and health care startup that aims to bring safe, science-backed products to the market for kidney health. Founded in 2020, the company is led by a team of dedicated kidney researchers and industry professionals, some of whom have been personally affected by kidney disease, providing a unique perspective. Their flagship product, KetoCitra, is the first medical food designed to support individuals with mild to moderate stages of polycystic kidney disease (ADPKD). The company's focus on research-backed ingredients and commitment to raising awareness about polycystic kidney disease sets it apart in the health care and pharmaceutical industries. In March 2021, Santa Barbara Nutrients secured a significant $1.23M Seed Round investment, reflecting the confidence of investors in the company's mission and potential impact. This investment signifies a strong show of support for the startup's innovative approach to kidney health and its potential to break new ground in the field. Headquartered in the United States, Santa Barbara Nutrients seeks to address the critical need for products and information related to kidney health. By harnessing the power of science and a deep-rooted commitment to the community, the company is poised to make a meaningful difference in the lives of individuals affected by polycystic kidney disease. With its strong foundation and innovative product line, Santa Barbara Nutrients is well-positioned to make a significant impact in the biotechnology and health care sectors. For more information, visit their website at Santa Barbara Nutrients.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round | $1.23M | - | 03 Mar 2021 |
No recent news or press coverage available for Santa Barbara Nutrients.